[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Gastrointestinal Stromal Tumor Market Research Report 2024(Status and Outlook)

February 2024 | 108 pages | ID: GEE94EDDA381EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.

This report provides a deep insight into the global Gastrointestinal Stromal Tumor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumor market in any manner.

Global Gastrointestinal Stromal Tumor Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Sun Pharmaceutical

Pfizer

Bayer Aktiengesellschaft

NATCO Pharma

Market Segmentation (by Type)

Stomach

Small Intestine

Others

Market Segmentation (by Application)

Hospitals

Clinics

Specialized Cancer Treatment Centers

Other End Users

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Gastrointestinal Stromal Tumor Market
  • Overview of the regional outlook of the Gastrointestinal Stromal Tumor Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor
1.2 Key Market Segments
  1.2.1 Gastrointestinal Stromal Tumor Segment by Type
  1.2.2 Gastrointestinal Stromal Tumor Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GASTROINTESTINAL STROMAL TUMOR MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Gastrointestinal Stromal Tumor Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Gastrointestinal Stromal Tumor Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GASTROINTESTINAL STROMAL TUMOR MARKET COMPETITIVE LANDSCAPE

3.1 Global Gastrointestinal Stromal Tumor Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Stromal Tumor Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Stromal Tumor Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Stromal Tumor Market Competitive Situation and Trends
  3.6.1 Gastrointestinal Stromal Tumor Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 GASTROINTESTINAL STROMAL TUMOR INDUSTRY CHAIN ANALYSIS

4.1 Gastrointestinal Stromal Tumor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 GASTROINTESTINAL STROMAL TUMOR MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Stromal Tumor Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Stromal Tumor Price by Type (2019-2024)

7 GASTROINTESTINAL STROMAL TUMOR MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Stromal Tumor Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Stromal Tumor Sales Growth Rate by Application (2019-2024)

8 GASTROINTESTINAL STROMAL TUMOR MARKET SEGMENTATION BY REGION

8.1 Global Gastrointestinal Stromal Tumor Sales by Region
  8.1.1 Global Gastrointestinal Stromal Tumor Sales by Region
  8.1.2 Global Gastrointestinal Stromal Tumor Sales Market Share by Region
8.2 North America
  8.2.1 North America Gastrointestinal Stromal Tumor Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Gastrointestinal Stromal Tumor Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Gastrointestinal Stromal Tumor Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Gastrointestinal Stromal Tumor Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Gastrointestinal Stromal Tumor Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Novartis
  9.1.1 Novartis Gastrointestinal Stromal Tumor Basic Information
  9.1.2 Novartis Gastrointestinal Stromal Tumor Product Overview
  9.1.3 Novartis Gastrointestinal Stromal Tumor Product Market Performance
  9.1.4 Novartis Business Overview
  9.1.5 Novartis Gastrointestinal Stromal Tumor SWOT Analysis
  9.1.6 Novartis Recent Developments
9.2 Sun Pharmaceutical
  9.2.1 Sun Pharmaceutical Gastrointestinal Stromal Tumor Basic Information
  9.2.2 Sun Pharmaceutical Gastrointestinal Stromal Tumor Product Overview
  9.2.3 Sun Pharmaceutical Gastrointestinal Stromal Tumor Product Market Performance
  9.2.4 Sun Pharmaceutical Business Overview
  9.2.5 Sun Pharmaceutical Gastrointestinal Stromal Tumor SWOT Analysis
  9.2.6 Sun Pharmaceutical Recent Developments
9.3 Pfizer
  9.3.1 Pfizer Gastrointestinal Stromal Tumor Basic Information
  9.3.2 Pfizer Gastrointestinal Stromal Tumor Product Overview
  9.3.3 Pfizer Gastrointestinal Stromal Tumor Product Market Performance
  9.3.4 Pfizer Gastrointestinal Stromal Tumor SWOT Analysis
  9.3.5 Pfizer Business Overview
  9.3.6 Pfizer Recent Developments
9.4 Bayer Aktiengesellschaft
  9.4.1 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Basic Information
  9.4.2 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product Overview
  9.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product Market Performance
  9.4.4 Bayer Aktiengesellschaft Business Overview
  9.4.5 Bayer Aktiengesellschaft Recent Developments
9.5 NATCO Pharma
  9.5.1 NATCO Pharma Gastrointestinal Stromal Tumor Basic Information
  9.5.2 NATCO Pharma Gastrointestinal Stromal Tumor Product Overview
  9.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Product Market Performance
  9.5.4 NATCO Pharma Business Overview
  9.5.5 NATCO Pharma Recent Developments

10 GASTROINTESTINAL STROMAL TUMOR MARKET FORECAST BY REGION

10.1 Global Gastrointestinal Stromal Tumor Market Size Forecast
10.2 Global Gastrointestinal Stromal Tumor Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Gastrointestinal Stromal Tumor Market Size Forecast by Country
  10.2.3 Asia Pacific Gastrointestinal Stromal Tumor Market Size Forecast by Region
  10.2.4 South America Gastrointestinal Stromal Tumor Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Stromal Tumor by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Gastrointestinal Stromal Tumor Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor by Type (2025-2030)
  11.1.2 Global Gastrointestinal Stromal Tumor Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor by Type (2025-2030)
11.2 Global Gastrointestinal Stromal Tumor Market Forecast by Application (2025-2030)
  11.2.1 Global Gastrointestinal Stromal Tumor Sales (K Units) Forecast by Application
  11.2.2 Global Gastrointestinal Stromal Tumor Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumor Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumor Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Stromal Tumor Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Stromal Tumor Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Stromal Tumor Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor as of 2022)
Table 10. Global Market Gastrointestinal Stromal Tumor Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Stromal Tumor Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Stromal Tumor Product Type
Table 13. Global Gastrointestinal Stromal Tumor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Stromal Tumor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor Market Challenges
Table 22. Global Gastrointestinal Stromal Tumor Sales by Type (K Units)
Table 23. Global Gastrointestinal Stromal Tumor Market Size by Type (M USD)
Table 24. Global Gastrointestinal Stromal Tumor Sales (K Units) by Type (2019-2024)
Table 25. Global Gastrointestinal Stromal Tumor Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Stromal Tumor Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Stromal Tumor Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Stromal Tumor Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gastrointestinal Stromal Tumor Sales (K Units) by Application
Table 30. Global Gastrointestinal Stromal Tumor Market Size by Application
Table 31. Global Gastrointestinal Stromal Tumor Sales by Application (2019-2024) & (K Units)
Table 32. Global Gastrointestinal Stromal Tumor Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Stromal Tumor Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Stromal Tumor Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Stromal Tumor Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Stromal Tumor Sales by Region (2019-2024) & (K Units)
Table 37. Global Gastrointestinal Stromal Tumor Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Stromal Tumor Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gastrointestinal Stromal Tumor Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gastrointestinal Stromal Tumor Sales by Region (2019-2024) & (K Units)
Table 41. South America Gastrointestinal Stromal Tumor Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gastrointestinal Stromal Tumor Sales by Region (2019-2024) & (K Units)
Table 43. Novartis Gastrointestinal Stromal Tumor Basic Information
Table 44. Novartis Gastrointestinal Stromal Tumor Product Overview
Table 45. Novartis Gastrointestinal Stromal Tumor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Gastrointestinal Stromal Tumor SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Sun Pharmaceutical Gastrointestinal Stromal Tumor Basic Information
Table 50. Sun Pharmaceutical Gastrointestinal Stromal Tumor Product Overview
Table 51. Sun Pharmaceutical Gastrointestinal Stromal Tumor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Sun Pharmaceutical Business Overview
Table 53. Sun Pharmaceutical Gastrointestinal Stromal Tumor SWOT Analysis
Table 54. Sun Pharmaceutical Recent Developments
Table 55. Pfizer Gastrointestinal Stromal Tumor Basic Information
Table 56. Pfizer Gastrointestinal Stromal Tumor Product Overview
Table 57. Pfizer Gastrointestinal Stromal Tumor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Pfizer Gastrointestinal Stromal Tumor SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Basic Information
Table 62. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product Overview
Table 63. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bayer Aktiengesellschaft Business Overview
Table 65. Bayer Aktiengesellschaft Recent Developments
Table 66. NATCO Pharma Gastrointestinal Stromal Tumor Basic Information
Table 67. NATCO Pharma Gastrointestinal Stromal Tumor Product Overview
Table 68. NATCO Pharma Gastrointestinal Stromal Tumor Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. NATCO Pharma Business Overview
Table 70. NATCO Pharma Recent Developments
Table 71. Global Gastrointestinal Stromal Tumor Sales Forecast by Region (2025-2030) & (K Units)
Table 72. Global Gastrointestinal Stromal Tumor Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Gastrointestinal Stromal Tumor Sales Forecast by Country (2025-2030) & (K Units)
Table 74. North America Gastrointestinal Stromal Tumor Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Gastrointestinal Stromal Tumor Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Gastrointestinal Stromal Tumor Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Gastrointestinal Stromal Tumor Sales Forecast by Region (2025-2030) & (K Units)
Table 78. Asia Pacific Gastrointestinal Stromal Tumor Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Gastrointestinal Stromal Tumor Sales Forecast by Country (2025-2030) & (K Units)
Table 80. South America Gastrointestinal Stromal Tumor Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Gastrointestinal Stromal Tumor Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Gastrointestinal Stromal Tumor Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Gastrointestinal Stromal Tumor Sales Forecast by Type (2025-2030) & (K Units)
Table 84. Global Gastrointestinal Stromal Tumor Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Gastrointestinal Stromal Tumor Price Forecast by Type (2025-2030) & (USD/Unit)
Table 86. Global Gastrointestinal Stromal Tumor Sales (K Units) Forecast by Application (2025-2030)
Table 87. Global Gastrointestinal Stromal Tumor Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Gastrointestinal Stromal Tumor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Stromal Tumor Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Stromal Tumor Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor Market Size by Country (M USD)
Figure 11. Gastrointestinal Stromal Tumor Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Stromal Tumor Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Stromal Tumor Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Stromal Tumor Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Stromal Tumor by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Stromal Tumor by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Stromal Tumor by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Stromal Tumor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Stromal Tumor Market Share by Application
Figure 24. Global Gastrointestinal Stromal Tumor Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Stromal Tumor Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Stromal Tumor Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Stromal Tumor Market Share by Application in 2023
Figure 28. Global Gastrointestinal Stromal Tumor Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Stromal Tumor Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gastrointestinal Stromal Tumor Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gastrointestinal Stromal Tumor Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Stromal Tumor Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gastrointestinal Stromal Tumor Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gastrointestinal Stromal Tumor Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gastrointestinal Stromal Tumor Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gastrointestinal Stromal Tumor Sales and Growth Rate (K Units)
Figure 50. South America Gastrointestinal Stromal Tumor Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gastrointestinal Stromal Tumor Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gastrointestinal Stromal Tumor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gastrointestinal Stromal Tumor Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gastrointestinal Stromal Tumor Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gastrointestinal Stromal Tumor Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Stromal Tumor Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Stromal Tumor Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Stromal Tumor Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Stromal Tumor Market Share Forecast by Application (2025-2030)


More Publications